Pay in 4 interest-free payments of $7.27 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Clinical trials consistently demonstrate 10-12% body weight loss with monotherapy, and 15-25% when combined with semaglutide
Cardiovascular disease Homocysteine and cardiovascular disease The results of more than 80 observational studies indicate that even moderately elevated concentrations of homocysteine in the blood increase the risk of cardiovascular disease (CVD) (4)
Lupescu A, Jilani K, Zelenak C, Zbidah M, Qadri SM, Lang F
In Phase I clinical trials, the drug demonstrated significant weight loss potential with reductions up to 10.3% over 12 weeks
US$ 26.38
US$ 28.19
US$ 28.51
US$ 28.23
US$ 27.24
US$ 24.70
US$ 27.95
US$ 29.53
